Senior HEOR Expert - Rare Disease & Global Access

UCB

Brussel

Hybride

EUR 70 000 - 110 000

Plein temps

Il y a 7 heures

Soyez parmi les premiers à postuler

Générateur de candidature

Démarquez-vous pour ce poste — générez un CV personnalisé et une lettre de motivation en environ une minute.

Passez les filtres ATS

Résumé du poste

UCB is seeking a Health Economics & Outcomes Research Senior Expert (Rare Disease) to develop and execute global HEOR strategies supporting payer, HTA, and reimbursement objectives across product lifecycles. You will influence development programs and shape evidence generation plans to meet diverse healthcare systems and payer needs across markets.

You will collaborate with cross-functional teams, design cost-effectiveness and budget impact studies, contribute to value dossiers, and help

Qualifications

Master's degree or PhD in Health Economics, Outcomes Research, Market Access, Public Health, Epidemiology, Pharmacy, or related discipline.
Strong experience within HEOR, Market Access, Outcomes Research, or Health Economics in the pharmaceutical, biotechnology, or consulting sectors.
Expertise in health economic modelling, cost-effectiveness analyses, budget impact modelling, and outcomes research methodologies.
Experience supporting HTA submissions, reimbursement processes, and payer evidence requirements across multiple markets.
Rare Disease experience is highly desirable.
Experience working across regions or at a global/intercontinental level, with a strong understanding of diverse healthcare systems and payer environments.

Responsabilités

Support the development and execution of global HEOR and payer evidence strategies aligned with asset and market access objectives.
Design and deliver HEOR studies and deliverables, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, HCRU studies, and HRQoL research.
Develop asset value assessments and economic value frameworks to support pricing, reimbursement, and access decisions.
Shape and communicate compelling economic value stories for assigned assets and indications.
Influence clinical development programs to ensure evidence generation plans address HTA and payer requirements, including evolving EU HTA needs.
Contribute to global value dossiers and support affiliates in the development of robust market access and reimbursement strategies.
Partner with cross-functional teams to deliver evidence generation initiatives such as patient preference studies, natural history studies, and other outcomes research programs.
Provide HEOR expertise and guidance throughout the product lifecycle, helping translate evidence into successful access outcomes.
Contribute to scientific publications, congress presentations, abstracts, posters, and external scientific engagement activities.
Support innovation and continuous improvement by sharing best practices, methodologies, and emerging approaches across the HEOR community.